News | 04 February 2013
He has a track record as a founder, active investor in and director of more than 20 innovative healthcare and life-science companies over the last 12 years including companies that are have successfully exited ? such as Arakis, Cambridge Biotechnology ...
Click on the link to read the full article at Business Weekly
(This link will open in a new window)